Literature DB >> 12835704

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.

Melissa Pope1, Ashley T Haase.   

Abstract

By the acute stage of HIV-1 infection, the immune system already faces daunting challenges. Research on mucosal barriers and the events immediately after heterosexual transmission that precede this acute stage could facilitate the development of effective microbicides and vaccines.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12835704     DOI： 10.1038/nm0703-847

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  137 in total

1.  Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.

Authors:  Martha Stefanidou; Carolina Herrera; Naomi Armanasco; Robin J Shattock
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses.

Authors:  Fabien P Blanchet; Arnaud Moris; Damjan S Nikolic; Martin Lehmann; Sylvain Cardinaud; Romaine Stalder; Eduardo Garcia; Christina Dinkins; Florence Leuba; Li Wu; Olivier Schwartz; Vojo Deretic; Vincent Piguet
Journal:  Immunity       Date:  2010-05-06       Impact factor: 31.745

Review 3.  Dangerous liaisons at the virological synapse.

Authors:  Vincent Piguet; Quentin Sattentau
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

4.  Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells.

Authors:  Bangxing Hong; Xiao-Tong Song; Lisa Rollins; Lindsey Berry; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

5.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

Review 6.  Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.

Authors:  Diana Finzi; Susan F Plaeger; Carl W Dieffenbach
Journal:  Clin Vaccine Immunol       Date:  2006-07

7.  HIV binding, penetration, and primary infection in human cervicovaginal tissue.

Authors:  Diane Maher; Xiaoyun Wu; Timothy Schacker; Julie Horbul; Peter Southern
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

8.  The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells.

Authors:  Patricia Fletcher; Yana Kiselyeva; Greg Wallace; Joseph Romano; George Griffin; Leonid Margolis; Robin Shattock
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.

Authors:  Bradford K Berges; Sarah R Akkina; Joy M Folkvord; Elizabeth Connick; Ramesh Akkina
Journal:  Virology       Date:  2008-01-18       Impact factor: 3.616

10.  SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission.

Authors:  Theresa L Chang; Natalia Teleshova; Aprille Rapista; Maciej Paluch; Robert A Anderson; Donald P Waller; Lourens J D Zaneveld; Angela Granelli-Piperno; Mary E Klotman
Journal:  FEBS Lett       Date:  2007-08-31       Impact factor: 4.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.